Company Monitoring Page for Shire

latest headlines for company on cafepharma

Shire to Forest on Deal List for AstraZeneca: Real M&A
Bloomberg
Tue, 02/12/13 - 12:13 pm
Tags:
Shire, Forest Labs, AstraZeneca, M&A
Shire, Impax settle litigation related to Adderall XR
Yahoo/Reuters
Fri, 02/8/13 - 11:12 am
Tags:
Shire, Impax Laboratories, Adderall XR
Feds grab Shire's attention on Adderall marketing
Fierce Pharma
Mon, 02/4/13 - 12:23 pm
Tags:
Shire, Adderall, ADHD
Shire CEO to Retire in 2013; Bayer’s Ornskov Gets Top Job
Bloomberg
Thu, 10/25/12 - 11:50 am
Tags:
Shire, Bayer, Pharma CEOs, Angus Russell, Flemming Ornskov
Protalix Biotherapeutics: Eyes On Elelyso Sales And Advancing Pipeline
Seeking Alpha
Mon, 10/1/12 - 11:28 am
Tags:
Protalix BioTherapeutics, Elelyso, Pfizer, Sanofi, Shire, ProCellEx
Biogen, Shire, Novo top pharma ranking of shareholder value
Fierce Pharma
Tue, 09/18/12 - 12:54 pm
Tags:
BiogenIdec, Shire, Novo Nordisk
Shire settles 1 Intuniv patent infringement lawsuit; Anchen can market generic in July 2016
Yahoo/AP
Fri, 09/7/12 - 12:02 pm
Tags:
Shire, Intuniv, patents, Anchen, TWi Pharmaceuticals
4 Pharmaceutical Stocks to Sell Now
InvestorPlace
Sat, 08/25/12 - 12:43 pm
Tags:
Warner Chilcott, Shire, Sagent Pharmaceuticals, Pemix Therapeutic Holdings
Shire calms jitters on ADHD drug growth
Reuters
Wed, 08/1/12 - 11:03 am
Tags:
ADHD, Shire, earnings
Pfizer May Sink On New Drug Woes
Seeking Alpha
Tue, 07/10/12 - 11:15 am
Tags:
Pfizer, Abbott Laboratories, Bristol-Myers Squibb, Shire, Watson Pharmaceuticals
GlaxoSmithKline dips on renewed talk of interest in US group BioMarin
Guardian, UK
Thu, 06/28/12 - 12:49 pm
Tags:
GSK, Biomarin, M&A, Shire
Shire Seen Luring Pfizer To Teva With Lowest Valuation: Real M&A
Bloomberg
Thu, 06/28/12 - 12:46 pm
Tags:
Shire, Pfizer, Teva Pharmaceuticals, M&A
Shire Falls Most Since 2005 On Actavis’s Adderall Generic
Bloomberg
Mon, 06/25/12 - 11:07 am
Tags:
Shire, generics, Actavis, Adderall, ADHD
Pfizer Should Rise On New Gaucher Drug, Due Out In 2013
Seeking Alpha
Tue, 05/8/12 - 10:53 am
Tags:
Pfizer, Gaucher disease, GSK, AstraZeneca, Eli Lilly, Shire, Protalix BioTherapeutics, Elelyso
Deals Of The Week: Will Lightning Strike Twice At Shire
In Vivo Blog
Sat, 04/14/12 - 01:03 pm
Tags:
Shire, Pervasis Therapeutics, regenerative medicine
Shire scoops up Pervasis Therapeutics
Mass High Tech
Fri, 04/13/12 - 09:59 am
Tags:
Pervasis Therapeutics, Shire, M&A, regenerative medicine
Growing popularity of virtual biotechs promises boon to outsourcers
Fierce CRO
Thu, 03/22/12 - 12:16 pm
Tags:
outsourcing, virtual biotech, Shire, FerroKin, Stromedix, Biogen Idec
Protalix: What You Need To Know Ahead Of The May 1 PDUFA Date
Seeking Alpha
Wed, 03/21/12 - 10:01 am
Tags:
FDA, Pfizer, Sanofi, Shire, taliglucerase alfa, Gaucher disease, Protalix BioTherapeutics
Shire Withdraws Bid For Fabry Drug In The US
Pharmalot
Thu, 03/15/12 - 09:43 am
Tags:
Replagal, Shire, Fabry's disease
Shire to buy U.S. biotech firm FerroKin for up to $325 million
Reuters
Thu, 03/15/12 - 09:41 am
Tags:
Shire, FerroKin, M&A

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.